Skip to main content

Table 4 Ordinary Least Squares model weighted in two stages with instrumental variables incorporated for condom use

From: Estimating the effectiveness of self-help groups on the adoption of secondary preventive measures by people living with HIV in Central America, 2012

Variables

Categories

 

1st stage: Intervention vs. control

2nd stage:

Condom use

   

Coeff

CI

Coeff

CI

Country

El Salvador

 

1.000

  

1.000

  

Belice

 

0.453*

0.397

0.508

0.343

−0.131

0.818

Costa Rica

 

− 0.042

− 0.111

0.025

− 0.079

− 0.162

0.002

Guatemala

 

0.426*

0.374

0.477

0.144

−0.293

0.581

Honduras

 

0.230*

0.177

0.283

0.184

−0.063

0.433

Panama

 

0.432*

0.380

0.483

0.224

−0.227

0.675

Age (years)

16–24

 

1.000

  

1.000

  

25–44

 

−0.033

−0.077

0.010

0.062

−0.001

0.127

45–59

 

−0.046

−0.099

0.006

0.023

−0.054

0.100

≥60

 

− 0.050

−0.132

0.031

−0.037

− 0.147

0.072

Schooling

None

 

1.00

  

1.000

  

Literate

 

−0.015

−0.107

0.076

0.042

−0.080

0.164

6 years

 

−0.066*

−0.110

− 0.022

0.016

− 0.073

0.105

12 years

 

− 0.116*

−0.164

− 0.068

0.036

− 0.095

0.167

≥16 years

 

−0.057

− 0.119

0.004

0.044

−0.052

0.141

Sex

Female

 

1.000

  

1.000

  

Male

 

0.035*

0.000

0.070

0.122*

0.071

0.172

Sexual orientation

Heterosexual

 

1.000

  

1.00

  

Bisexual

 

0.029

0.029

−0.035

0.054

− 0.020

0.129

Homosexual

 

0.007

0.007

−0.040

0.099*

0.042

0.157

Currently in a stable relationship

No

 

1.000

  

1.000

  

Yes

 

0.017

−0.013

0.048

0.201*

0.164

0.238

Average

Monthly income

0–2581 USD

 

−0.000

− 0.000

0.000

0.000

−5.480

0.000

Family support

No

 

1.000

  

1.000

  

Yes

 

0.037*

0.002

0.071

0.022

−0.031

0.076

Economic dependents

No

 

1.000

  

1.000

  

Yes

 

−0.009

− 0.042

0.024

0.021

−0.016

0.060

History of pulmonary tuberculosis

No

 

1.000

  

1.000

  

Yes

 

0.029

−0.011

0.070

− 0.056*

− 0.111

− 0.001

Received counseling when tested for HIV

No

 

1.000

  

1.000

  

Yes

 

−0.023

−0.065

0.019

0.024

− 0.029

0.078

History of drug use

No

 

1.000

  

1.000

  

Yes

 

−0.037

−0.092

0.016

0.045

−0.019

0.110

Future time perspective (scale)

 

1

0.058

−0.054

0.172

0.662*

0.403

0.922

2

−0.235*

− 0.463

− 0.006

0.588*

0.197

0.980

3

−0.269*

−0.531

− 0.006

0.472*

0.065

0.878

4

−0.252*

−0.418

− 0.086

0.746*

0.431

1.061

5

−0.260*

−0.376

− 0.144

0.647*

0.351

0.943

6

−0.215*

−0.307

− 0.122

0.626*

0.379

0.873

7

−0.182*

−0.270

− 0.094

0.718*

0.504

0.933

 

8

−0.152*

−0.243

− 0.062

0.797*

0.611

0.983

 

9

−0.265*

−0.354

− 0.175

0.845*

0.554

1.136

  

10

−0.133*

−0.237

− 0.028

0.700*

0.489

0.910

Distance to SHG

Km (Euclidean)

 

−0.000*

−0.001

− 0.000

–

–

–

Distance to SHG - squared Euclidean

Km (Euclidean)

 

4.170*

1.140

7.210

–

–

–

Participation

Control

 

–

–

–

   
 

Intervention

 

–

–

–

−0.252

−1.296

0.791

  1. Source: prepared by the author based on data from the following project: Elaboration of the risk profile of people living with HIV in the beneficiary countries of the REDCA+ Regional Program; *p < 0.05; overidentification test: p = 0.861; endogeneity test: p = 0.265; weakness test: p = 0.024 (F = 3.71)